SynBioGov · A framework for the fair and responsible governance of synthetic biology
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2021-09-01 → 2024-03-21
- EU contribution
- €183,473
- Participants
- 1
- Scheme
- MSCA-IF
Lines connect the coordinator with its partners.
Results in brief
A framework for the fair and responsible governance of synthetic biology
Positioned in the context of international environmental law and governance, the SynBioGov project aims at developing an integrative conceptual framework for the fair and responsible governance of synthetic biology. Synthetic biology refers to an emerging interdisciplinary area of science and technology that involves the application of engineering principles to biology. Far from being a homogeneous field, it encompasses a wide range of enabling methodologies such as DNA sequencing, and tools associated with novel biotechnologies such as gene editing, all aiming at the (re-)design and fabrication of biological components and systems that do not already exist in the natural world. Synthetic biology has progressed by leaps and bounds in recent years, accompanied by great promises and grave risks. At the same time, law and governance lag behind. While legal orders at the national and regional level are struggling, lab experimentation and field trials take place in a legal vacuum. Developments related to synthetic biology pose challenges for the legal frameworks regulating both access to genetic resources (the raw material for biotechnological innovation) and fair and equitable sharing of the benefits arising from their use, and biosafety (the safety of biotechnological applications for the environment and human/animal health). Global deliberations on these two aspects, covering the environmental and socio-economic impacts of synthetic biology, are held under the auspices of UN multilateral environmental agreements, including the Convention on Biological Diversity (CBD). An additional challenge relates to the diverse communities of actors that have arisen around synthetic biology. Previous waves of biotechnological innovation were confined in companies and research institutes. On top of these traditional actors, a do-it-yourself (DIY) community engages in synbio research, claiming to democratize science and problem-solving. Aiming at empirically-rich and policy-relevant socio-legal analysis, the SynBioGov project covers both the macro-level (global institutions and multilateral environmental agreements) and the micro-level (actors involved in lab research), also addressing the institutional structures for risk management and practices for responsible research and innovation that connect them. It includes: • an assessment of the current state of international environmental law, including an analysis of regulatory gaps and normative challenges regarding both biosafety and equity and justice-related objectives, with focus on the CBD and the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA); • a review of social sciences literature on risk and innovation, including gendered approaches; and • development of an exploratory typology of actors involved in synthetic biology research, including their claims and motivations. The resulting framework builds on the principles of fairness and safety to promote global justice outcomes, further aiming to improve accountability of decision makers and actors involved in research, and enhance the legitimacy both of decision making and of the innovation process. Using a Third World Approaches to International Law (TWAIL) analytical lens, it approaches biotechnology governance through a decolonized approach to international law scholarship and science and technology studies (STS).
Data: CORDIS, © European Union
Project objective
Synthetic biology aims to exercise control in the design, characterization and construction of living organisms and biological parts. No longer the domain of science fiction literature, it has progressed by leaps and bounds in recent years, accompanied by great promises and grave risks. Law and governance lag behind. Lab experimentation and field trials take place in a legal vacuum. On top of companies and research institutes, a vibrant do-it-yourself community is engaged in research, claiming to democratize innovation. Global deliberations on the environmental and socio-economic impacts have only recently begun under the auspices of UN multilateral environmental agreements, and policy-relevant academic analysis is urgently needed. Based on my academic record in international environmental law and governance of novel technologies and my empirical knowledge of intergovernmental negotiations, complemented by training in socio-legal methodologies during the fellowship, I will develop a new integrative framework for the governance of synthetic biology. It will be built upon: a) an assessment of the current state of international law and governance, including an analysis of regulatory gaps and novel normative challenges; b) an examination of existing theoretical frameworks on risk management and responsible research and innovation, including gendered approaches to risk that have been understudied to date; and c) a typology of actors involved in synthetic biology research, including an analysis of who does what, why, and how they envisage regulation, with a particular focus on gene editing in agriculture. Aiming at improving accountability and enhancing legitimacy, both of law and governance and of the innovation process, this framework will not only bridge gaps in scholarly efforts but will also facilitate decision making, ensuring that synthetic biology applications promote the global objectives of food security, sustainable agriculture and environmental protection.
Original text from CORDIS.
Participants
- UNIVERSITA DEGLI STUDI DI TRENTO · TrentoCoordinatorItaly
Links
- View on CORDIS
- DOI: 10.3030/101029634
- https://www.sis.unitn.it/2749/a-framework-for-the-fair-and-responsible-governance-of-synthetic-biology
Data: CORDIS, © European Union
